afib and semaglutide GLP-1 drugs outperform SGLT-2 drugs for patients with type 2 diabetes Exploring Semaglutide's Cardiovascular Impact -
Description
As a GLP-1 medicine, semaglutide also has appetite-suppressing properties
Do not stop either medication without medical guidance
Men with diabetes respond to PDE-5 inhibitors, though average response rates can be a bit lower than in non-diabetic mendose-titration and adherence to instructions (timing, arousal) help improve results (systematic review in diabetes
Before the But there are also cases where new and serious side effects are discovered after the drug has been on the market
Myth: You will never crave sugar again
